TEVATeva Pharmaceutical

Median target
$44
calls from the last 12 months
Implied return
+12.3%
median target vs. price
Coverage
11 analysts · 14 calls
updated in the last 12 months
Consensus
11/0/0+11 net
Buy / Hold / Sell

Which analysts are behind TEVA's consensus?

See every current rating, price target and the analysts' track records for Teva Pharmaceutical — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 11 analysts with calls on TEVA updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

TEVA elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-08-21InsidersWeiss AmirChief Accounting OfficerInsider sale6.9K sh @ $37.61$261K
2026-08-21InsidersWeiss AmirChief Accounting OfficerInsider sale2.5K sh @ $37.63$94K
2026-08-21InsidersSatchi-Fainaro RonitDirectorInsider sale415 sh @ $37.25$15K
2026-08-17InsidersLippman EvanEVP, Business DevelopmenInsider sale18.6K sh @ $36.57 · planned trade$680K
2026-08-05InsidersZaks Tal ZviDirectorInsider sale17 sh @ $34.87$593
2026-08-03InsidersHughes Eric ASee "Remarks"Insider sale25.6K sh @ $34.88 · planned trade$892K
2026-08-03InsidersJover PlacidSee "Remarks"Insider sale12.8K sh @ $34.88 · planned trade$447K
2017-01-30CongressCheri BustosIL-IL17Salesince trade +16.7%, vs market +271.0%$1K–$15K
2016-05-11CongressK. Michael ConawayTX-TX11Salesince trade -19.1%, vs market +353.2%$1K–$15K
2016-05-04CongressK. Michael ConawayTX-TX11Salesince trade -23.5%, vs market +360.8%$1K–$15K

More: congressional trades on TEVA · insider activity · executive branch · trending